MX2009003912A - Metodos y composiciones usando compuestos inmunomoduladores para el tratamiento y manejo de enfermedades bacterianas por espiroquetas y otras bacterias intracelulares obligadas. - Google Patents
Metodos y composiciones usando compuestos inmunomoduladores para el tratamiento y manejo de enfermedades bacterianas por espiroquetas y otras bacterias intracelulares obligadas.Info
- Publication number
- MX2009003912A MX2009003912A MX2009003912A MX2009003912A MX2009003912A MX 2009003912 A MX2009003912 A MX 2009003912A MX 2009003912 A MX2009003912 A MX 2009003912A MX 2009003912 A MX2009003912 A MX 2009003912A MX 2009003912 A MX2009003912 A MX 2009003912A
- Authority
- MX
- Mexico
- Prior art keywords
- spirochete
- methods
- compositions
- management
- treatment
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title abstract 2
- 241000589970 Spirochaetales Species 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 2
- 230000003834 intracellular effect Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describen métodos para tratar, prevenir y/o manejar una enfermedad o rastorno bacteriano por espiroqueta y/o bacteria intracelular obligada. Los métodos específicos abarcan la administración de un compuesto inmunomodulador solo o en combinación con un segundo agente activo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85284606P | 2006-10-19 | 2006-10-19 | |
PCT/US2007/022388 WO2008057196A2 (en) | 2006-10-19 | 2007-10-19 | Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009003912A true MX2009003912A (es) | 2009-05-11 |
Family
ID=39364972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009003912A MX2009003912A (es) | 2006-10-19 | 2007-10-19 | Metodos y composiciones usando compuestos inmunomoduladores para el tratamiento y manejo de enfermedades bacterianas por espiroquetas y otras bacterias intracelulares obligadas. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20110184025A1 (es) |
EP (1) | EP2081561A2 (es) |
JP (1) | JP2010506937A (es) |
CN (1) | CN101557806A (es) |
AP (1) | AP2009004834A0 (es) |
CA (1) | CA2665778A1 (es) |
MX (1) | MX2009003912A (es) |
WO (1) | WO2008057196A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8405379B1 (en) | 2008-09-18 | 2013-03-26 | Luc Montagnier | System and method for the analysis of DNA sequences in biological fluids |
US8257938B2 (en) * | 2009-02-27 | 2012-09-04 | Medical Diagnostic Laboratories, Llc | Hemolysin and its protein fragments in sero-detection of Anaplasma phagocytophilum |
RS56232B1 (sr) | 2010-02-11 | 2017-11-30 | Celgene Corp | Derivati arilmetoksi izoindolina i kompozicije koje ih obuhvataju i postupci njihove primene |
EP2753932A4 (en) * | 2011-09-07 | 2015-07-15 | Alpha Biotech Ab | DETERMINATION OF BACTERIAL INFECTIONS OF THE GENUS RICKETTSIA AND, WHERE APPROPRIATE, BORRELIA IN BLOOD-SPENDING PATIENTS WITH DISEASE SYMPTOMS |
WO2013113000A2 (en) | 2012-01-26 | 2013-08-01 | Luc Montagnier | Detection of dna sequences as risk factors for hiv infection |
US9839632B2 (en) | 2013-04-02 | 2017-12-12 | Celgene Corporation | Methods and compositions using 4-amino-2-(2,6-dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment and management of central nervous system cancers |
EP2815749A1 (en) | 2013-06-20 | 2014-12-24 | IP Gesellschaft für Management mbH | Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7182953B2 (en) * | 1999-12-15 | 2007-02-27 | Celgene Corporation | Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders |
ES2290091T3 (es) * | 2000-11-30 | 2008-02-16 | The Children's Medical Center Corporation | Sintesis de enantiomeros de 4-amino-talidomida. |
DE60231989D1 (de) * | 2001-08-06 | 2009-05-28 | Childrens Medical Center | Antiangiogenese wirkung von stickstoffsubstituierten thalidomid-analoga |
US7968569B2 (en) * | 2002-05-17 | 2011-06-28 | Celgene Corporation | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
US7323479B2 (en) * | 2002-05-17 | 2008-01-29 | Celgene Corporation | Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
EP1505973B1 (en) * | 2002-05-17 | 2010-03-03 | Celgene Corporation | Combinations for treating multiple myeloma |
US7189740B2 (en) * | 2002-10-15 | 2007-03-13 | Celgene Corporation | Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes |
CN1326522C (zh) * | 2002-10-24 | 2007-07-18 | 细胞基因公司 | 用于治疗、改变和控制疼痛的包含免疫调节化合物的组合物 |
-
2007
- 2007-10-19 EP EP07867254A patent/EP2081561A2/en not_active Withdrawn
- 2007-10-19 AP AP2009004834A patent/AP2009004834A0/xx unknown
- 2007-10-19 CA CA002665778A patent/CA2665778A1/en not_active Abandoned
- 2007-10-19 CN CNA2007800457918A patent/CN101557806A/zh active Pending
- 2007-10-19 JP JP2009533401A patent/JP2010506937A/ja active Pending
- 2007-10-19 WO PCT/US2007/022388 patent/WO2008057196A2/en active Application Filing
- 2007-10-19 MX MX2009003912A patent/MX2009003912A/es not_active Application Discontinuation
- 2007-10-19 US US12/446,227 patent/US20110184025A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2081561A2 (en) | 2009-07-29 |
US20110184025A1 (en) | 2011-07-28 |
WO2008057196A2 (en) | 2008-05-15 |
AP2009004834A0 (en) | 2009-04-30 |
JP2010506937A (ja) | 2010-03-04 |
WO2008057196A3 (en) | 2008-07-24 |
CA2665778A1 (en) | 2008-05-15 |
CN101557806A (zh) | 2009-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200631578A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury | |
HK1121936A1 (en) | Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels | |
MX2009003912A (es) | Metodos y composiciones usando compuestos inmunomoduladores para el tratamiento y manejo de enfermedades bacterianas por espiroquetas y otras bacterias intracelulares obligadas. | |
EP2079500A4 (en) | DEVICES AND METHODS FOR INFUSION | |
AU2008232453A8 (en) | Methods and compositions for reduction of side effects of therapeutic treatments | |
MX361467B (es) | Compuestos de isoindolina para uso en el tratamiento de cancer. | |
MY150602A (en) | Subtituted-quinoxaline-type piperidine compounds and the uses thereof | |
WO2012027065A3 (en) | Combination therapy for treatment of disease | |
IL174965A0 (en) | SUBSTITUTED BENZAZOLES AND USE THEREOF AS INHIBITORS OF Raf KINASE | |
AP1913A (en) | Substituted benzazoles and use thereof as raf kinase inhibitors | |
WO2009002867A3 (en) | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement | |
MX2011011950A (es) | Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas. | |
MY150697A (en) | Methods of treating cancer using pyridopyrimdinone inhibitors of p13k alpha | |
TW200718689A (en) | 2-Amino-quinazolin-5-ones | |
GB2467670A (en) | Chemical entities and therapeutic uses thereof | |
ZA200701629B (en) | Gyrase inhibitors and uses thereof | |
MY150797A (en) | Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer | |
TW200716628A (en) | Novel compounds | |
MX2008011633A (es) | Aminoquinolonas como inhibidores de gsk-3. | |
MX2007006066A (es) | Inhibidores de jnk para el tratamiento de lesiones del snc. | |
MX2010008921A (es) | Derivados de oxazolidinona. | |
MY153948A (en) | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof | |
MX2008015775A (es) | Compuestos y composiciones para tratamiento de cancer. | |
MX2010001574A (es) | Ligandos del receptor cannabinoide. | |
BRPI0916885B8 (pt) | composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |